Louis, E., Delooze, D., Deprez, P., Heartburn in Belgium: Prevalence, impact on daily life and utilization of medical resources (2002) Eur. J. Gastroenterol. Hepatol., 14, pp. 279-284
Ruth, M., Mansson, I., Sandberg, N., The prevalence of symptoms, suggestive of oesophageal disorders (1991) Scand. J. Gastroenterol., 26, pp. 73-81
Jones, R.H., Lydeard, S.E., Hobbs, F.D., Kenkre, J.E., Williams, E.I., Jones, S.J., Dyspepsia in England and Scotland (1990) Gut, 31, pp. 401-405
Bruley Des Varannes, S., Galmiche, J.P., Bernades, P., Bader, J.P., Douleurs épigastriques et régurgitations: Épidémiologie descriptive dans un échantillon représentatif de la population française adulte (1988) Gastroenterol. Clin. Biol., 12, pp. 721-728
Revicki, D., Wood, M., Maton, P., Sorensen, S., The impact of gastro-oesophageal reflux disease on health related quality of life (1998) Am. J. Med., 104, pp. 252-258
Trimble, K.C., Douglas, S., Pryde, H.N.C., Clinical characteristics and natural history of symptomatic but not excess gastro-esophageal reflux (1995) Dig. Dis. Sci., 40, pp. 1098-1104
Van Pinxteren, B., Numans, M.E., Bonis, P.A., Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-esophageal reflux disease-like symptoms and endoscopy negative reflux disease (Cochrane Review) (2003) The Cochrane Library, (1). , Oxford: Update Software
Wayman, J., Hayes, N., Raimes, S.A., Prescription of proton pump inhibitors before endoscopy. A potential cause of missed diagnosis of early gastric cancer (2000) Arch. Fam. Med., 9, pp. 385-388
Fennerty, M.B., Extraesophageal gastroesophageal reflux disease (1999) Gastroenterology Clinics N. Am., 28, pp. 861-873
Fass, R., Empirical trials in the treatment of gastroesophageal reflux disease (2000) Dig. Dis., 18, pp. 20-26
Eisendrath, P., Tack, J., Deviere, J., Diagnosis of gastroesophageal reflux disease in general practice: A Belgian national survey (2002) Endoscopy, 34, pp. 998-1003